APA (7th ed.) Citation

Tsakiridou, G., Angelerou, M., Efentakis, P., Margaritis, A., Papanastasiou, A., & Kalantzi, L. (2025). Partial AUCs in Long-Acting Injectables: Rationale, Challenges, Variability, Usefulness, and Clinical Relevance. Pharmaceutics, 17(1), 21. https://doi.org/10.3390/pharmaceutics17010021

Chicago Style (17th ed.) Citation

Tsakiridou, Georgia, Maria-Faidra-Galini Angelerou, Panagiotis Efentakis, Antonios Margaritis, Antigoni-Maria Papanastasiou, and Lida Kalantzi. "Partial AUCs in Long-Acting Injectables: Rationale, Challenges, Variability, Usefulness, and Clinical Relevance." Pharmaceutics 17, no. 1 (2025): 21. https://doi.org/10.3390/pharmaceutics17010021.

MLA (9th ed.) Citation

Tsakiridou, Georgia, et al. "Partial AUCs in Long-Acting Injectables: Rationale, Challenges, Variability, Usefulness, and Clinical Relevance." Pharmaceutics, vol. 17, no. 1, 2025, p. 21, https://doi.org/10.3390/pharmaceutics17010021.